Ignite Creation Date:
2024-05-06 @ 2:14 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04253535
Status:
COMPLETED
Last Update Posted:
2020-12-02
First Post:
2020-01-31
Brief Title:
Risk of Recurrence of Cervical Artery Dissection During Pregnancy and Puerperium
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Study Overview
Official Title:
A Prospective Study to Evaluate the Risk of Recurrence of Cervical Artery Dissection During Subsequent Pregnancies
Status:
COMPLETED
Status Verified Date:
2020-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cervical artery dissection CAD accounts for about 2 of all strokes and is a major cause of stroke in young people about 15 Many cases of CAD during pregnancy and puerperium have been described suggesting that pregnancy and puerperium may be potential risk factors for CAD The purpose of this study is to determine whether pregnancy and puerperium are also recurrence risk factors for CAD
Detailed Description:
In this study all women of childbearing age who had had a CAD between 2005 and 2017 are selected Women are identified using the ICD10 diagnostic coding system In addition a text search with key words cervical or carotid or vertebral dissection has been created in a data warehouse of the University Hospital of Nantes
To determine the recurrence of CAD during pregnancy and puerperium the participating women will be asked to answer to a questionnaire by phone or mail The questionnaire will be conducted by the same investigator an experienced neurologist Information about recurrence of CAD number of pregnancies before and after the event will be recorded as well as the site of obstetrical monitoring way of delivery and management of antithrombotics in case of further pregnancy In case of no further pregnancy after the dissection the reason will be explored
To determine the recurrence of CAD during pregnancy and puerperium the participating women will be asked to answer to a questionnaire by phone or mail The questionnaire will be conducted by the same investigator an experienced neurologist Information about recurrence of CAD number of pregnancies before and after the event will be recorded as well as the site of obstetrical monitoring way of delivery and management of antithrombotics in case of further pregnancy In case of no further pregnancy after the dissection the reason will be explored
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None